M

Myomo Inc
AMEX:MYO

Watchlist Manager
Myomo Inc
AMEX:MYO
Watchlist
Price: 0.831 USD 0.85%
Market Cap: $32m

Myomo Inc
Total Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Myomo Inc
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
M
Myomo Inc
AMEX:MYO
Total Assets
$38.6m
CAGR 3-Years
56%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Total Assets
$43.7B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
9%
Edwards Lifesciences Corp
NYSE:EW
Total Assets
$13.7B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
14%
Stryker Corp
NYSE:SYK
Total Assets
$47.8B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Total Assets
$86.7B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Assets
$20.5B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Myomo Inc
Glance View

Market Cap
32m USD
Industry
Health Care

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.

MYO Intrinsic Value
1.46 USD
Undervaluation 43%
Intrinsic Value
Price $0.831
M

See Also

What is Myomo Inc's Total Assets?
Total Assets
38.6m USD

Based on the financial report for Dec 31, 2025, Myomo Inc's Total Assets amounts to 38.6m USD.

What is Myomo Inc's Total Assets growth rate?
Total Assets CAGR 5Y
21%

Over the last year, the Total Assets growth was -9%. The average annual Total Assets growth rates for Myomo Inc have been 56% over the past three years , 21% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett